Clinical Trials Directory

Trials / Unknown

UnknownNCT02609360

Effects of Different Crystalloid Solutions for Extra-corporeal Membrane Oxygenator (ECMO) Priming

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
45 (estimated)
Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Crystalloid solutions modify acid-base equilibrium according to their electrolyte composition. Moreover, it has been suggested that these alterations are generated by the difference between the solution strong ion difference (SID) and the plasma bicarbonate level. An increased risk of acute kidney injury and renal replacement therapy has been associated to the infusion of chloride rich crystalloids. This study aims to compare, in patients with acute respiratory failure undergoing ECMO support, the effects on acid-base status and renal function of crystalloids commonly employed for circuit priming to a balanced solution created with a SID equal to patients' bicarbonate level.

Conditions

Interventions

TypeNameDescription
OTHERPriming of ECMO circuit with 0.9% NaCl0.9% NaCl as priming crystalloid solution
OTHERPriming of ECMO circuit with Ringer LactateRinger Lactate as priming crystalloid solution
OTHERPriming of ECMO circuit with Balanced SolutionBalanced Solution as priming crystalloid solution

Timeline

Start date
2013-05-01
Primary completion
2016-07-01
First posted
2015-11-20
Last updated
2015-11-20

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT02609360. Inclusion in this directory is not an endorsement.